🇺🇸 FDA
Patent

US 11376214

Compositions and methods for treatment of ocular diseases

granted A61KA61K31/4709A61K31/55

Quick answer

US patent 11376214 (Compositions and methods for treatment of ocular diseases) held by KIORA PHARMACEUTICALS GmbH expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KIORA PHARMACEUTICALS GmbH
Grant date
Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4709, A61K31/55, A61K31/7036, A61K47/36